By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Northwest Biotherapeutics, Inc. 

21720 23rd Drive SE, Suite 100

Bothell  Washington  98021  U.S.A.
Phone: 425-608-3000-or-877-606-9246-Toll-Free Fax: 425-608-3026


SEARCH JOBS


Industry
Services


Collaborations

Cytogen Corporation  Development of ex vivo prostate cancer immunotherapy





Company News
Northwest Biotherapeutics (NWBO) Reports Promising Survival Data In 51 Gbm Patients Treated With Dcvax-L 3/27/2015 7:24:57 AM
Northwest Biotherapeutics (NWBO) To Present At The 2nd Immunotherapy Of Cancer Conference, ITOC-2 3/24/2015 11:22:04 AM
Northwest Biotherapeutics (NWBO)'s Phase 3 Trial Of Dcvax-L For Gbm Brain Cancer Approved To Proceed In Canada And Under Way At Two Sites 2/19/2015 11:07:29 AM
Northwest Biotherapeutics (NWBO) To Present At 17th Annual BIO CEO & Investor Conference 2/9/2015 11:25:31 AM
Northwest Biotherapeutics (NWBO) To Present At The 7th Annual Phacilitate Immunotherapy Forum 1/23/2015 10:38:39 AM
Northwest Biotherapeutics (NWBO) To Present At Biotech Showcase Conference 1/8/2015 2:37:10 PM
Northwest Biotherapeutics (NWBO) Recaps 2014 Progress, Provides Dcvax-Direct Trial Update At Oppenheimer's 25th Annual Healthcare Conference 12/12/2014 8:11:48 AM
Northwest Biotherapeutics (NWBO) Reports $35M In Financing 11/20/2014 5:58:07 AM
Northwest Biotherapeutics (NWBO) Release: DCVAX®-L Hospital Exemption Program Now Under Way In Germany 10/14/2014 12:50:20 PM
Northwest Biotherapeutics (NWBO) Secures $11.5 Million Financing 10/7/2014 7:11:59 AM
12345678910...
//-->